Biggest News Aggregation in the World
📰 Rezolute Inc News

Page 2 - Rezolute Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rezolute Inc. Real-time updates on events, politics, business and more.

Silverarc Capital Management LLC Cuts Holdings in Rezolute, Inc. (NASDAQ:RZLT)

Silverarc Capital Management LLC decreased its position in Rezolute, Inc. (NASDAQ:RZLT – Free Report) by 13.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 433,240 shares of the company’s stock after selling 66,304 shares during the period. Silverarc Capital Management LLC owned about 1.18% […]
United States Silverarc Capital Management Rezolute Inc Renaissance Technologies Northern Trust Corp Worth Venture Partners
Source: wkrb13.com

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update

13.02.2024 - Phase 3 clinical study of RZ358 underway in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Benefit shown in individual patient cases with RZ358 for tumor-associated hyperinsulinism (taHI) under Expanded Access ...
Christen Baglaneas Nevan Charles Elam Daron Evans Stephanie Carrington Regulatory Agency European Medicines Agency

Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket - argenx (NASDAQ:ARGX), Aclarion (NASDAQ:ACON)

Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)."
Robert Carey Steelcase Inc Nogin Inc Technology Group Inc Renewables Limited Group Inc

Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital Hyperinsulinism

REDWOOD CITY, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today
Stephanie Carrington Nevan Charles Elam Rezolute Inc Securities Exchange European Medicines Agency Chief Executive Officer

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Caxton Corp Has $2.61 Million Position in Rezolute, Inc. (NASDAQ:RZLT)

Caxton Corp reduced its holdings in Rezolute, Inc. (NASDAQ:RZLT – Free Report) by 6.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,318,967 shares of the company’s stock after selling 84,190 shares during the quarter. Rezolute accounts for 7.5% of Caxton Corp’s […]
United States Rezolute Inc Cantor Fitzgerald Northern Trust Corp Exchange Commission Caxton Corp

Rezolute (NASDAQ:RZLT) PT Lowered to $7.00

Rezolute (NASDAQ:RZLT – Free Report) had its target price trimmed by JMP Securities from $8.00 to $7.00 in a research note released on Tuesday morning, Benzinga reports. The firm currently has a market outperform rating on the stock. A number of other analysts have also issued reports on RZLT. Cantor Fitzgerald reissued an overweight rating […]
United States Worth Venture Partners Rezolute Inc Stonepine Capital Management Vanguard Group Inc Northern Trust Corp
Source: wkrb13.com

Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for ...

REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today
United States Stephanie Carrington Susan Stewart European Medicines Agency Securities Exchange European Union

Rezolute (NASDAQ:RZLT) Shares Down 2.6%

Rezolute, Inc. (NASDAQ:RZLT – Get Free Report) shares were down 2.6% during mid-day trading on Friday . The stock traded as low as $0.81 and last traded at $0.87. Approximately 51,270 shares were traded during mid-day trading, an increase of 58% from the average daily volume of 32,480 shares. The stock had previously closed at […]
United States Rezolute Inc Rezolute Company Profile Charles Schwab Investment Management Inc Millennium Management Cantor Fitzgerald

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science